HMSM Members

Not all patients are suitable candidates for CAR T-cell therapy. Careful patient selection is essential to maximize benefit and minimize risk. Eligibility depends on cancer type, disease stage, prior treatments, and overall health status.

Patients must have sufficient organ function to tolerate treatment and potential side effects. Active infections, severe organ dysfunction, or uncontrolled neurological conditions may limit eligibility.

Comprehensive evaluation by a multidisciplinary team ensures appropriate patient selection. This process includes laboratory testing, imaging studies, and detailed medical history review.

Selecting the right patient is a critical step in achieving successful CAR T-cell therapy outcomes.